You can buy or sell ITOS and other stocks, options, and ETFs commission-free!
iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA. The listed name for ITOS is iTeos Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 25, Pre-Market